BR9909679A - Proteìna tao quinases e processos para seu uso - Google Patents

Proteìna tao quinases e processos para seu uso

Info

Publication number
BR9909679A
BR9909679A BR9909679-0A BR9909679A BR9909679A BR 9909679 A BR9909679 A BR 9909679A BR 9909679 A BR9909679 A BR 9909679A BR 9909679 A BR9909679 A BR 9909679A
Authority
BR
Brazil
Prior art keywords
processes
kinases
protect
mitogen
presented
Prior art date
Application number
BR9909679-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Melanie Cobb
Michele Hutchinson
Zhu Chen
Kevin Berman
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Publication of BR9909679A publication Critical patent/BR9909679A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
BR9909679-0A 1998-04-14 1999-04-14 Proteìna tao quinases e processos para seu uso BR9909679A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/060,410 US6165461A (en) 1998-04-14 1998-04-14 Tao protein kinases and methods of use therefor
PCT/US1999/008165 WO1999053076A1 (en) 1998-04-14 1999-04-14 Tao protein kinases and methods of use therefor

Publications (1)

Publication Number Publication Date
BR9909679A true BR9909679A (pt) 2000-12-19

Family

ID=22029289

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9909679-0A BR9909679A (pt) 1998-04-14 1999-04-14 Proteìna tao quinases e processos para seu uso

Country Status (8)

Country Link
US (2) US6165461A (https=)
EP (1) EP1071787A1 (https=)
JP (1) JP2002515223A (https=)
CN (1) CN100374568C (https=)
AU (1) AU758731B2 (https=)
BR (1) BR9909679A (https=)
CA (1) CA2325824A1 (https=)
WO (1) WO1999053076A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6165461A (en) 1998-04-14 2000-12-26 Board Of Regents, University Of Texas System Tao protein kinases and methods of use therefor
US7078182B1 (en) 1998-04-14 2006-07-18 Board Of Regents, The University Of Texas System TAO protein kinase polypeptides and methods of use therefor
US7148330B2 (en) * 1999-07-30 2006-12-12 Schering Corporation Binding compounds for IL-27
EP1409656A4 (en) * 2001-03-12 2005-01-12 Darley Pharmaceuticals Ltd SCREENING OF PHEROMONAL COMPOUNDS OF NON-STEROID AND NON-PEPTIDE INVERTEBRATE HAVING ACTIVITY MODULATING MITOGEN-ACTIVATED PROTEIN KINASE
US6806293B1 (en) * 2001-03-12 2004-10-19 Darley Pharmaceuticals Ltd Use of pheromone compounds having MAP kinase modulating activity
WO2002099044A2 (en) * 2001-06-05 2002-12-12 Exelixis, Inc. B3galts as modifiers of the p53 pathway and methods of use
AU2002324598A1 (en) * 2001-08-06 2003-02-24 Exelixis, Inc. Trps as modifiers of the p53 pathway and methods of use
WO2003051905A2 (en) * 2001-12-13 2003-06-26 Exelixis, Inc. Taojiks as modifiers of the beta-catenin pathway and methods of use
WO2004012817A2 (en) * 2002-07-31 2004-02-12 Kylix B.V. Use of genes identified to be involved in tumor development for the development of anti-cancer drugs
US7282479B2 (en) * 2003-03-31 2007-10-16 Ttc Co., Ltd. Hyperthermia agent for malignant tumor comprising cytokine and magnetic fine particles
EP1514558A1 (en) * 2003-09-15 2005-03-16 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Use of MARKK or MARKK antagonists for the treatment of pathologies characterised by increased or reduced phosphorylation of MARK or tau protein
US20100122354A1 (en) * 2005-06-20 2010-05-13 Exelixis, Inc. Cdc6s as modifiers of the pten/akt pathway and methods of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4326097A (en) * 1996-07-03 1998-01-21 Chiron Corporation (mitogen-activated protein kinase) kinase-3 (mkk3) interacting protein (mip)
AU8296698A (en) * 1997-07-08 1999-02-08 Cadus Pharmaceutical Corporation (kds) protein kinase molecules and uses related thereto
US6165461A (en) 1998-04-14 2000-12-26 Board Of Regents, University Of Texas System Tao protein kinases and methods of use therefor

Also Published As

Publication number Publication date
WO1999053076A9 (en) 2001-03-15
CN100374568C (zh) 2008-03-12
US6586242B1 (en) 2003-07-01
AU3560599A (en) 1999-11-01
EP1071787A1 (en) 2001-01-31
AU758731B2 (en) 2003-03-27
US6165461A (en) 2000-12-26
CA2325824A1 (en) 1999-10-21
WO1999053076A1 (en) 1999-10-21
JP2002515223A (ja) 2002-05-28
CN1303435A (zh) 2001-07-11

Similar Documents

Publication Publication Date Title
DK552684A (da) Desulfatohirudiner samt deres fremstilling og anvendelse
BR0316234A (pt) Hidroxiindóis, seu uso como inibidores de fosfodiesterase 4 e processos para a preparação dos mesmos
BR9911488A (pt) Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou de profilaxia de doenças inflamatórias, e para a preparação de um composto
BR9909679A (pt) Proteìna tao quinases e processos para seu uso
BR9911482A (pt) Composto, composição farmacêutica, uso do composto, e, processos para o tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto
FI905531A0 (fi) Transdermalisk anvaendning av 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobensotiazol.
ATE245977T1 (de) Therapeutische substituierte guanidine
BR0211863A (pt) 1-alquil ou 1-cicloalquiltriazolo[4,3a]quinazolin-5-onas como inibidores da fosfodiesterase
TR200002616T2 (tr) Simetrik ve simetrik olmayan sübstitüe edilmiş difenil üreler kullanılarak raf kinazın inhibe edilmesi
DK209088D0 (da) Medicinpraeparater, deres fremstilling og anvendelse
ATE529109T1 (de) Hemmung der p38 kinase aktivität durch substituierte heterocyclische harnstoffe
BR0113176A (pt) Compostos biciclo-pirazol, composições farmacêuticas compreendendo os compostos, uso dos compostos na fabricação de medicamentos, processos para a preparação dos compostos, coleção quìmica combinatória e métodos para o tratamento de mamìferos incluindo humanos utilizando os compostos
FI935585A0 (fi) Pyrrolopyrimidiner
DK328585D0 (da) Modificerede succinimider, fremgangsmaade til deres fremstilling samt deres anvendelse
TR200002617T2 (tr) Aril ve heteroaril sübstitüentli heterosiklik üreler kullanılarak RAF kinazın inhibe edilmesi
BR9907270A (pt) Composto, composição farmacêutica, uso de um composto, e, processos para tratamento ou profilaxia de doenças inflamatórias, por exemplo, asma ou copd, e para a preparação de um composto
TR199800012T1 (xx) Piroloprimidinler ve preparasyon i�in tatbikler.
YU49101A (sh) Karboksiaril supstituisani difenil karbamidi kao inhibitori raf kinaze
EE200000093A (et) Agrekanaasi ja maatriksmetalloproteinaaside uudsed inhibiitorid artriidi käitlemiseks
BR9814080A (pt) Uso de compostos para atividade anti-prurìtica
TR200101756T2 (tr) Protein kinaz inhibitörleri olarak 4,5-pirazinoksindoller.
DE69010294D1 (de) Verwendung von Antiprogestomimetika zur Stimulierung des Eisprungs.
DK175837B1 (da) Interleukin I inhibitorer, fremgangsmåder til fremstilling deraf samt deres anvendelse til terapeutiske formål
DK393382A (da) Aminoorganoaminosilaner, fremgangsmaade til fremstilling heraf samt deres anvendelse
ES2086359T3 (es) R(-)-1-(5-hidroxihexil)-3-metil-7-propilxantina, procedimiento para su preparacion y medicamentos que contienen este compuesto.

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: DE ACORDO COM O ART. 36 DA LPI (LEI 9279/96) 2O, O PEDIDO VOLTA A EXAME SENDO CONSIDERADO NAO PATENTEAVEL PELAS RAZOES EXPOSTAS NO PARECER TECNICO ANTERIOR. PORTANTO, INDEFIRO O PRESENTE PEDIDO DE PATENTE COMO INVENCAO - DE ACORDO COM OS ARTIGOS 8O, 10 (VIII), 10 (IX), 13, 18 (III), 24 E 25 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.